tiprankstipranks
Inmune Bio (INMB)
NASDAQ:INMB
US Market
INMB
Inmune Bio
RESEARCH TOOLSreports
Want to see INMB full AI Analyst Report?

Inmune Bio (INMB) Financial Statements

877 Followers

Inmune Bio Financial Overview

Inmune Bio's market cap is currently $35.09M. The company's EPS TTM is $-0.198; its P/E ratio is -0.90; Inmune Bio is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 50.00K$ 14.00K$ 155.00K$ 374.00K$ 181.00K
Gross Profit$ 50.00K$ 14.00K$ 155.00K$ 374.00K$ 181.00K
Operating Income$ -30.87M$ -42.63M$ -29.74M$ -25.95M$ -29.15M
EBITDA$ -30.79M$ -42.08M$ 0.00$ 0.00$ 0.00
Net Income$ -45.93M$ -42.08M$ -30.01M$ -27.30M$ -30.34M
Balance Sheet
Cash & Short-Term Investments$ 24.75M$ 20.92M$ 35.85M$ 52.15M$ 74.81M
Total Assets$ 32.35M$ 39.56M$ 57.00M$ 81.80M$ 99.94M
Total Debt$ 1.03M$ 384.00K$ 10.44M$ 15.31M$ 15.23M
Net Debt$ -23.72M$ -20.54M$ -25.41M$ -36.84M$ -59.58M
Total Liabilities$ 8.83M$ 7.46M$ 18.86M$ 21.69M$ 19.72M
Stockholders' Equity$ 23.52M$ 32.10M$ 38.14M$ 60.10M$ 80.22M
Cash Flow
Free Cash Flow$ -23.62M$ -33.36M$ -11.98M$ -22.69M$ -43.50M
Operating Cash Flow$ -22.58M$ -33.36M$ -11.98M$ -22.69M$ -28.50M
Investing Cash Flow$ -1.04M$ 0.00$ 0.00$ 0.00$ -15.00M
Financing Cash Flow$ 27.61M$ 18.21M$ -4.22M$ 729.00K$ 96.36M
Currency in USD

Inmune Bio Earnings and Revenue History

Income Statement >

Inmune Bio Debt to Assets

Balance Sheet >

Inmune Bio Cash Flow

Cash Flow >

Inmune Bio Forecast EPS vs Actual EPS

Earnings >